Fortis Malar Hospitals (BOM:523696) Risk Assessment

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:523696 Fortis Malar Hospitals Ltd BOM:523696
33 GF Score
Price ₹41.95
! 1 Warning Sign
View Full Analysis

What is Fortis Malar Hospitals Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Fortis Malar Hospitals is: No Data: Cannot be evaluated.

Fortis Malar Hospitals  (BOM:523696) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Fortis Malar Hospitals Risk Assessment Related Terms

BOM:523696 vs HCA, THC, EHC: Risk Assessment Comparison

For the Medical Care Facilities subindustry, Fortis Malar Hospitals's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fortis Malar Hospitals Risk Assessment vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fortis Malar Hospitals's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Fortis Malar Hospitals's Risk Assessment falls into.


BOM:523696
33GF Score
Fortis Malar Hospitals Ltd BOM:523696
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fortis Malar Hospitals Business Description

Address Fortis Hospital, Sector 62, Phase VIII, Mohali, PB, IND, 160062
Fortis Malar Hospitals Ltd is an India-based company engaged in the provision of healthcare services. It focuses on providing medical care in the areas of cardiology and cardiac surgery, neurosurgery, gynecology, orthopedics, gastroenterology, neurology, pediatrics, diabetes, nephrology, and internal medicine. The company provides healthcare services in various branches of medicine such as general surgery, general medicine, pediatrics, neurology, cardiology, ophthalmology, radiology, pathology, gastroenterology, urology, thoracic surgery, plastic surgery, and other allied specialties. It operates in one business, namely, in the health care services.
33GF Score

Get the complete analysis for BOM:523696

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹41.95
Price